tadalafil has been researched along with Prostatic Neoplasms in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (12.12) | 29.6817 |
| 2010's | 24 (72.73) | 24.3611 |
| 2020's | 5 (15.15) | 2.80 |
| Authors | Studies |
|---|---|
| Amodeo, P; Arroyo, FJ; Bianchini, G; De Petrocellis, L; López-Alvarado, P; Martín, MA; Menéndez, JC; Orlando, P; Roncero, C; Sánchez, A; Schiano Moriello, A; Vitale, RM | 1 |
| Antinozzi, C; Aversa, A; Di Luigi, L; Greco, EA; Sgrò, P | 1 |
| Baccaglini, W; Corrêa Barros, EA; Glina, S; Monteiro, L; Navas, A; Pazeto, CL; Saad Rached, RY; Timóteo, F | 1 |
| Antonioni, A; Aversa, A; Bimonte, VM; Brunetti, A; Curreli, M; Ferretti, E; Fittipaldi, S; Lenzi, A; Marampon, F; Migliaccio, S; Pestell, RG; Vitale, G | 1 |
| Fukazawa, A; Hashida, I; Iijima, K; Ishizuka, O; Kato, H; Koiwai, K; Minagawa, T; Ogawa, T; Oguchi, T; Saitou, T | 1 |
| Haga, N; Miyazaki, T; Okabe, Y; Tsubouchi, K | 1 |
| Bertolo, R; De Cillis, S; Fiori, C; Geuna, S; Manfredi, M; Porpiglia, F | 1 |
| Brock, G; Büttner, H; Chevallier, D; Dickson, R; Henneges, C; Krajka, K; Moncada, I; Montorsi, F; Mulhall, J; Patel, HR; Stolzenburg, JU | 1 |
| Burnett, AL | 1 |
| Brock, G; Büttner, H; Henneges, C; Montorsi, F; Mulhall, J | 1 |
| Bruner, DW; Buyyounouski, MK; Greenberg, RE; Kachnic, LA; Mowat, RB; Pervez, N; Pisansky, TM; Pugh, SL; Raben, A; Reed, DR; Rosenthal, SA | 1 |
| Büttner, H; Graefen, M; Henneges, C; Kriegel, C; Manning, M; Martin Morales, A; Michl, U; Pommerville, PJ; Schostak, M; Stolzenburg, JU | 1 |
| Atış, G; Canat, L; Çaşkurlu, T; Güner, B; Gürbüz, C | 1 |
| Casabé, A; Glina, S; Henneges, C; Roehrborn, CG; Sorsaburu, S; Viktrup, L | 1 |
| Andrianne, R; Barry, J; Branicka, J; Büttner, H; Chadwick, D; Cuzin, B; Hell-Momeni, K; Henneges, C; Ilo, D; Patel, HR; Shah, N | 1 |
| Hashimoto, M; Hayashi, T; Kikuti, T; Minami, T; Nagai, Y; Nishimoto, M; Nozawa, M; Saitou, Y; Shimizu, N; Toyoda, S; Tsuji, H; Uemura, H; Yamamoto, Y; Yoshimura, K | 1 |
| Brock, G; Büttner, H; d'Anzeo, G; Henneges, C; Montorsi, F; Mulhall, JP; Oelke, M; Rossi, A; Salonia, A | 1 |
| Brock, G; Büttner, H; d'Anzeo, G; Fode, M; Henneges, C; Mulhall, JP; Oelke, M; Probst, KA; Rossi, A | 1 |
| Aydın, M; Balcı, MB; Bozkurt, A; Çakan, M; Hirik, E; Karabakan, M; Nuhoglu, B; Onuk, Ö | 1 |
| Gillatt, D; Goonewardene, SS; Persad, R | 1 |
| Seftel, AD | 1 |
| Deng, L; Han, P; Liu, L; Qiu, S; Tang, Z; Wei, Q; Yang, L | 1 |
| Hikita, K; Honda, M; Kawamoto, B; Morizane, S; Muraoka, K; Sejima, T; Takenaka, A | 1 |
| Badani, KK; Cheetham, P; Lee, DJ | 1 |
| Badellino, S; Ciammella, P; Filippi, AR; Gontero, P; Guarneri, A; Moretto, F; Munoz, F; Ragona, R; Ricardi, U; Rondi, N; Tizzani, A; Valentino, F | 1 |
| Hubanks, JM; Karnes, RJ; Myers, RP; Umbreit, EC | 1 |
| Barret, E; Cathala, N; Cathelineau, X; Djavan, B; Galiano, M; Giuliano, F; Jaffe, J; Kazzazi, A; Mombet, A; Prapotnich, D; Rozet, F; Sanchez-Salas, R; Vallancien, G | 1 |
| Fan, Y | 1 |
| Fox, PD; Peter, NM; Singh, MV | 1 |
| Hop, WC; Incrocci, L; Slagter, C; Slob, AK | 1 |
| Barbieri, L; Briganti, A; Dehò, F; Gallina, A; Guazzoni, G; Montorsi, F; Rigatti, P; Saccà, A; Salonia, A; Suardi, N; Zanni, G | 1 |
| Hop, WC; Incrocci, L; Slob, AK | 1 |
4 review(s) available for tadalafil and Prostatic Neoplasms
| Article | Year |
|---|---|
Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives.
Topics: Animals; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Hormones; Humans; Male; Phosphodiesterase 5 Inhibitors; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Steroids; Tadalafil; Treatment Outcome | 2022 |
Erectile function post robotic radical prostatectomy: technical tips to improve outcomes?
Topics: Adult; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Intraoperative Complications; Libido; Lithotripsy; Male; Middle Aged; Organ Sparing Treatments; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Preoperative Care; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Robotic Surgical Procedures; Tadalafil; Trauma, Nervous System; Treatment Outcome; Young Adult | 2016 |
Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer.
Topics: Adolescent; Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Sildenafil Citrate; Tadalafil; Treatment Outcome; Young Adult | 2016 |
[Tadalafil rehabilitation therapy for erectile dysfunction following prostatectomy].
Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Prostatectomy; Prostatic Neoplasms; Tadalafil | 2012 |
16 trial(s) available for tadalafil and Prostatic Neoplasms
| Article | Year |
|---|---|
The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial.
Topics: Aged; Erectile Dysfunction; Extracorporeal Shockwave Therapy; Humans; Male; Middle Aged; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Prostate; Prostatectomy; Prostatic Neoplasms; Tadalafil; Treatment Outcome | 2020 |
Impact of low-dose tadalafil on adverse events after low-dose-rate brachytherapy for prostate cancer: A bi-center randomized open-label trial.
Topics: Brachytherapy; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tadalafil; Treatment Outcome | 2021 |
Chitosan membranes applied on the prostatic neurovascular bundles after nerve-sparing robot-assisted radical prostatectomy: a phase II study.
Topics: Aged; Biocompatible Materials; Blood Vessels; Chitosan; Erectile Dysfunction; Feasibility Studies; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Peripheral Nerves; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Robotic Surgical Procedures; Tadalafil | 2018 |
Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
Topics: Adenocarcinoma; Aged; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil | 2014 |
Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial.
Topics: Adaptation, Psychological; Aged; Aged, 80 and over; Brachytherapy; Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Male; Marriage; Middle Aged; Patient Satisfaction; Prostatic Neoplasms; Radiation Injuries; Sexual Behavior; Tadalafil; Treatment Outcome; Vasodilator Agents | 2014 |
Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo.
Topics: Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil; Urological Agents | 2015 |
Effects of three-times-per-week versus on-demand tadalafil treatment on erectile function and continence recovery following bilateral nerve sparing radical prostatectomy: results of a prospective, randomized, and single-center study.
Topics: Aged; Carbolines; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Postoperative Period; Preoperative Period; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil; Treatment Outcome; Urinary Incontinence | 2015 |
Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing f
Topics: 5-alpha Reductase Inhibitors; Aged; Double-Blind Method; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Organ Size; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatism; Severity of Illness Index; Tadalafil | 2015 |
Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study.
Topics: Adenocarcinoma; Aged; Double-Blind Method; Humans; Interpersonal Relations; Male; Middle Aged; Patient Satisfaction; Prostatectomy; Prostatic Neoplasms; Quality of Life; Tadalafil; Urinary Incontinence; Vasodilator Agents | 2015 |
Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
Topics: Adenocarcinoma; Aged; Coitus; Decision Trees; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Phosphodiesterase 5 Inhibitors; Preoperative Period; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Robotic Surgical Procedures; Self Efficacy; Severity of Illness Index; Sexuality; Tadalafil | 2016 |
Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT).
Topics: Aged; Canada; Double-Blind Method; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil | 2016 |
Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy.
Topics: Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil; Treatment Outcome | 2016 |
Efficacy and safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: a randomized phase II trial.
Topics: Aged; Aged, 80 and over; Carbolines; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Medication Adherence; Middle Aged; Neoplasm Staging; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Tadalafil | 2010 |
Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.
Topics: Adult; Aged; Alprostadil; Carbolines; Coitus; Erectile Dysfunction; Humans; Laparoscopy; Male; Medication Adherence; Middle Aged; Organ Sparing Treatments; Orgasm; Penile Erection; Peripheral Nerves; Phosphodiesterase 5 Inhibitors; Postoperative Care; Prostate; Prostatectomy; Prostatic Neoplasms; Severity of Illness Index; Surveys and Questionnaires; Tadalafil; Vasodilator Agents | 2012 |
A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Carbolines; Coitus; Cross-Over Studies; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Prostatic Neoplasms; Radiotherapy, Conformal; Tadalafil; Treatment Outcome | 2006 |
Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial.
Topics: Aged; Carbolines; Cross-Over Studies; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prostatic Neoplasms; Radiotherapy, Conformal; Tadalafil | 2007 |
13 other study(ies) available for tadalafil and Prostatic Neoplasms
| Article | Year |
|---|---|
Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.
Topics: Animals; Antineoplastic Agents; Calcium; Cell Proliferation; Diketopiperazines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Prostatic Neoplasms; Structure-Activity Relationship; Tetrahydroisoquinolines; TRPM Cation Channels; Tumor Cells, Cultured; Urea | 2016 |
Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line.
Topics: Biomarkers; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hormones; Humans; Male; Phosphodiesterase 5 Inhibitors; Prostatic Neoplasms; Protein Transport; Receptors, Androgen; Signal Transduction; Steroids; Tadalafil | 2021 |
Editorial Comment to Impact of low-dose tadalafil on adverse events after low-dose-rate brachytherapy for prostate cancer: A bi-center randomized open-label trial.
Topics: Brachytherapy; Erectile Dysfunction; Humans; Male; Prostatic Neoplasms; Tadalafil | 2021 |
Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy.
Topics: Adenocarcinoma; Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil | 2014 |
Reply from authors re: Arthur L. Burnett. Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy. Eur Urol 2014;65:597-8: although erection rehabilitation after prostatectomy remains indefinite, the most effective treat
Topics: Adenocarcinoma; Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil | 2014 |
ED drugs after cancer treatment don't protect erectile function.
Topics: Carbolines; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil | 2014 |
[The Effect of Tadalafil on Sexual Function, Urinary Function and Health-Related Quality of Life in Patients Treated with Brachytherapy].
Topics: Brachytherapy; Humans; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Sexual Dysfunction, Physiological; Tadalafil; Urination | 2015 |
Re: Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil versus Placebo to Predict Recovery of Erectile Function after Bilateral Nerve-Sparing Radical Prostatectomy.
Topics: Erectile Dysfunction; Humans; Male; Penile Erection; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil | 2016 |
Impact of postoperative phosphodiesterase type 5 inhibitor treatment on lower urinary tract symptoms after robot-assisted radical prostatectomy: a longitudinal study.
Topics: Aged; Humans; Longitudinal Studies; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Postoperative Care; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Robotic Surgical Procedures; Tadalafil; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2017 |
Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency.
Topics: Carbolines; Erectile Dysfunction; Humans; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors; Piperazines; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Purines; Robotics; Sildenafil Citrate; Sulfones; Tadalafil; Trauma, Nervous System; Treatment Outcome | 2010 |
Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: a contemporary series.
Topics: Adult; Aged; Carbolines; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Neoplasm Grading; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Urinary Incontinence | 2012 |
Tadalafil-associated anterior ischaemic optic neuropathy.
Topics: Adenocarcinoma; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Optic Disk; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Prostatectomy; Prostatic Neoplasms; Tadalafil | 2005 |
Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy.
Topics: Carbolines; Erectile Dysfunction; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Patient Compliance; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Postoperative Complications; Prostate; Prostatectomy; Prostatic Neoplasms; Purines; Quality of Life; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Tadalafil; Time Factors; Treatment Outcome; Treatment Refusal; Triazines; Vardenafil Dihydrochloride | 2008 |